Identifying The Pitfalls Of Emerging Market M&A
This article was originally published in PharmAsia News
Executive Summary
While major pharma firms continue to see the "pharmerging" markets as attractive given their strong growth prospects, entrants should recognize the sometimes difficult challenges these opportunities can present, particularly for cross-border mergers and acquisitions.